◄ back to all posts

EBS: Emergent Biosolutions, Inc. Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,261.09
Enterprise Value ($M) 3,843.50
Book Value ($M) 987.50
Book Value / Share 19.21
Price / Book 3.28
NCAV ($M) -637.70
NCAV / Share -12.35
Price / NCAV -5.08

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.07

Liquidity (mrq)
Quick Ratio 1.28
Current Ratio 2.13

Balance Sheet (mrq) ($M)
Current Assets 528.50
Assets 2,153.70
Liabilities 1,166.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 89.80
Net Income 62.70
Earnings Per Share Diluted 1.22
Earnings Per Share Basic 1.25

Cash Flow Statement (mra) ($M)
Cash From Operations 41.80
Cash from Investing -897.20
Cash from Financing -897.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-12 13G/A Vanguard Group Inc 9.04 -3.42
2020-02-04 13G/A BlackRock Inc. 13.20 3.96
2019-02-08 13G/A Dimensional Fund Advisors Lp 3.32 -24.79
2016-02-12 13G/A Broadfin Capital, LLC 1.70
2016-01-11 13G/A Bank of New York Mellon Corp 4.81 274.63
2015-11-13 13G/A Loomis Sayles & Co L P 2.20

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-11-06 10-Q EBS / Emergent Biosolutions, Inc. 10-Q – Quarterly Report – 10-Q
2019-08-02 10-Q EBS / Emergent Biosolutions, Inc. 10-Q – Quarterly Report – 10-Q
2019-05-08 10-Q EBS / Emergent Biosolutions, Inc. 10-Q Quarterly Report 10-Q
2019-02-22 10-K EBS / Emergent Biosolutions, Inc. null (Annual Report)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-02-14 15,414 231,300 6.66
2020-02-13 19,785 279,200 7.09
2020-02-12 20,693 299,700 6.90
2020-02-11 13,823 190,200 7.27
2020-02-10 33,017 268,900 12.28

(click for more detail)

Similar Companies
BXLT – Baxalta Incorporated CBM – Cambrex Corp.
CTLT – Catalent Inc. HSP – Hospira
JNJ – Johnson & Johnson


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts
Retirement